|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||17.10 - 17.53|
|52 Week Range||16.81 - 53.96|
|PE Ratio (TTM)||221.79|
|Dividend & Yield||1.10 (6.46%)|
|1y Target Est||N/A|
Carrols Restaurant Group, GameStop, and TEVA Pharmaceuticals are all trading at a discount, but are any of them worth buying?
The biopharma successfully staved off a generic challenger for its most important drug.
Don’t buy the pain meds Citi is prescribing in Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). In our view, it’s too late to fill that order and this is a better occasion to take on a pick-me-up, contrarian position in TEVA with a bullish short-term options play. Apologies are a rare bird with analysts on Wall Street, and for that I almost want to tip the hat for Citi’s actions in TEVA stock.